Spatial molecular analyses reveal key features associated with response to KN026 in advanced HER2-positive breast cancer

Jianli Ma; Shengnan Sun; Xiaowen Tang; Jingxuan Wang; Wenhui Zhao; Dabei Tang; Ying Song; Liru Li; Haitao Luo; Xuhui Liu; Yuwei Deng; Qingyuan Zhang

doi:10.1038/s41416-025-03287-9

Abstract

Both HER2 and ESR1 are determinant of KN026 efficacy in advanced HER2-positive breast cancer, implying the potential of KN026 combined with endocrine therapy in HER2- and ER-positive breast cancer.

Affiliated Institutions

Related Publications

Triple-negative breast cancer molecular subtyping and treatment progress

Li Yin , Jiang-Jie Duan , Xiu-Wu Bian +1 more

Triple-negative breast cancer (TNBC), a specific subtype of breast cancer that does not express estrogen receptor (ER), progesterone receptor (PR), or human epidermal growth fac...

2020 Breast Cancer Research 2287 citations

Breast cancer

Sibylle Loibl , Philip Poortmans , Monica Morrow +2 more

Breast cancer is still the most common cancer worldwide. But the way breast cancer is viewed has changed drastically since its molecular hallmarks were extensively characterised...

2021 The Lancet 1433 citations

Breast cancer

Nadia Harbeck , Frédérique Penault‐Llorca , Javier Cortés +6 more

Breast cancer is the most frequent malignancy in women worldwide and is curable in ~70-80% of patients with early-stage, non-metastatic disease. Advanced breast cancer with dist...

2019 Nature Reviews Disease Primers 2678 citations

Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update

Kimberly H. Allison , M. Elizabeth H. Hammond , Mitch Dowsett +17 more

PURPOSE To update key recommendations of the American Society of Clinical Oncology/College of American Pathologists estrogen (ER) and progesterone receptor (PgR) testing in brea...

2020 Journal of Clinical Oncology 1292 citations

Incidence and implications of HER2 and hormonal receptor overexpression in newly diagnosed metastatic breast cancer (MBC)

F Penault–Llorca , Anne Vincent‐Salomon , M-C Mathieu +3 more

764 Background: Overexpression of the HER2 receptor protein predicts a worse prognosis and higher metastatic risk in patients (pts) with breast cancer. HER2 positivity also has ...

2005 Journal of Clinical Oncology 18 citations

Publication Info

Year: 2025
Type: article
Citations: 0
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Spatial molecular analyses reveal key features associated with response to KN026 in advanced HER2-positive breast cancer

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

OpenAlex

Cite This

APA Style

                            
                                    Jianli Ma, 
                                
                                    Shengnan Sun, 
                                
                                    Xiaowen Tang
                                
                                et al.
                            
                            (2025). 
                            Spatial molecular analyses reveal key features associated with response to KN026 in advanced HER2-positive breast cancer. 
                            British Journal of Cancer
                            
                            .
                            https://doi.org/10.1038/s41416-025-03287-9

Identifiers

DOI: 10.1038/s41416-025-03287-9